An international study identifies 11 genetic regions linked to borderline personality disorder
An international consortium has analyzed genetic data from nearly 13,000 people with borderline personality disorder (BPD) and more than one million without the diagnosis to identify the first genome regions associated with this disorder. This advance represents a significant leap in the biological understanding of a complex and often misunderstood disease, which affects nearly 2% of the Western population.
BPD generates a very strong emotional and social impact, mainly because it manifests as intense instability in emotions and relationships, with a high risk of self-harm and suicide. With this study, science begins to decipher the genetic basis behind it, opening the door to future therapies.
The keys to the genetic discovery about borderline personality disorder
How was the international study conducted?
The project combined data from 27 clinical studies and biobanks from 14 countries, coordinated from the Central Institute of Mental Health in Mannheim. The URV, together with HUIPM, IRB CatSud, and CIBERSAM, provided an independent cohort to confirm the main results. This collaboration allowed the analysis of more than one million genetic data points, the largest sample ever used for this disorder.
Which genetic regions have been identified?
Eleven genome regions and nine specific genes associated with BPD have appeared. These variants explain approximately 17% of the genetic risk, confirming that the disorder has a polygenic architecture, that is, caused by many genetic variants of small effect that add up impact, a characteristic shared with disorders such as schizophrenia or depression.
Relationship of BPD with other disorders and physical diseases
How does the genetic risk of BPD overlap with other diagnoses?
The results indicate a significant genetic overlap between BPD and other mental disorders such as post-traumatic stress disorder, depression, ADHD, and antisocial behavior, as well as with self-harm and suicide behaviors. This confirms that many psychiatric problems share common genetic mechanisms.
Is there any connection with physical diseases?
Interestingly, coincidences have also been detected with diseases such as chronic obstructive pulmonary disease, type 2 diabetes, obesity, and hypertension. This fact is crucial because an important part of the reduced life expectancy of people with BPD is due to physical problems, reinforcing the need to address health comprehensively.
Impact and future challenges for BPD research and care
What does this study mean for people with BPD and their environments?
The head of the GAP group, Elisabet Vilella, highlights that these biological evidences could help break the stigma that still weighs on BPD and affected families. Recognizing the genetic basis, comparable to that of other serious mental illnesses, gives more sense to the complexity of the disorder and the need for specific care.
What are the limitations and what future is expected for genetic research?
The samples analyzed come only from populations of European ancestry, which requires expanding research to more diverse groups. Moreover, the genetic risk scores obtained are useful for research but not for diagnosing or predicting the disorder individually. The results are shared with the entire scientific community to drive studies that, in the long term, can translate into new therapies.
With this study, research on BPD takes a giant step. Not only is a solid foundation established to understand the biology of the disorder, but a path is also opened to improve the quality of life of thousands of affected people. Genetics, combined with other factors, will shape the future of treatments.
Sources consulted
- Rovira i Virgili University – International genetic study on borderline personality disorder
- Nature Genetics – Original publication of the study by Streit et al. (2026)
Source of the article: Rovira i Virgili University
